The effects of protein hydrolysate-monosaccharide infusion on low-birth-weight infants.
D000666:Amphotericin B / Q000627:therapeutic use; D001724:Birth Weight; D001786:Blood Glucose / Q000378:metabolism; D001806:Blood Urea Nitrogen; D002136:Calcium, Dietary / Q000008:administration & dosage; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D009005:Monosaccharides / Q000008:administration & dosage; D010288:Parenteral Nutrition / Q000009:adverse effects; D011188:Potassium / Q000097:blood / Q000652:urine; D011492:Protein Hydrolysates / Q000008:administration & dosage*; D012131:Respiratory Insufficiency / Q000628:therapy; D012964:Sodium / Q000097:blood / Q000652:urine
D001786:Blood Glucose; D002136:Calcium, Dietary; D004040:Dietary Carbohydrates; D004044:Dietary Proteins; D009005:Monosaccharides; D011492:Protein Hydrolysates; D000666:Amphotericin B; D012964:Sodium; D011188:Potassium